Mr. Thomas Braun reports

VERISANTE TECHNOLOGY, INC. WELCOMES DR. KENNETH BEER AND DR. PHILIP WERSCHLER ONTO CLINICAL ADVISORY BOARD

Verisante Technology Inc. has appointed Dr. Kenneth Beer, MD, PA, and Dr. Wm. Philip Werschler, MD, FAAD, FAACS, to the company's clinical advisory board.

"Both Dr. Beer and Dr. Werschler have extensive experience assisting companies with setting up scientific advisory boards, advising with clinical studies and navigating the medical device regulatory regime in the United States," said Thomas Braun, president and chief executive officer. "We are fortunate to have two experts in their field join our advisory board and look forward to working closely together to further the objectives of Verisante."

Dr. Beer is a Florida-based board-certified dermatologist and dermatopathologist who has served the Palm Beach, Broward and Martin area for over 15 years, with offices in West Palm Beach and Jupiter. He is also a fellow of the American Academy of Dermatology, a fellow of the American Society of Dermatologic Surgery, volunteer assistant professor at the University of Miami, consulting associate with the Department of Medicine at Duke University and a member of the Thoracic Cancer Society.

"Verisante's technology certainly has the potential to make a significant impact on the clinical setting and patient outcomes when it is introduced into the United Stated," said Dr. Beer. "Not only can Aura meet the need for dermatologists and physicians with a skin specialty to have better tools to assist in diagnosing skin cancer, but as member of the Thoracic Cancer Society, I see the applications for the Core technology to be highly disruptive in the field."

Dr. Werschler, also a board certified dermatologist and skin cancer surgeon, is an internationally recognized expert in both medical and cosmetic dermatology/aesthetic surgery, and in this capacity he has been honoured to serve as a Food and Drug Administration investigator for clinical trials of both drugs and devices throughout his career. Today, nearly all of the FDA-approved aesthetic injectable dermal fillers and toxins were tested in his research centre, Premier Clinical Research, in Spokane, Wash. Dr. Werschler also has extensive experience in the conduct of investigative clinical trials for both precancerous lesions and skin cancers.

"I have been following Aura with intense interest for several years now and look forward to assisting in any investigative clinical trials that might be necessary to bring this exciting technology to the United States. The opportunity of non-invasive diagnosis for skin cancer is potentially a complete game changer in the clinical practice of dermatology and cutaneous oncology. The Aura combines emergent technology with patient-friendly evaluation of suspicious skin lesions for both melanoma and non-melanoma skin cancers. Any tool that can help a doctor become better at assessing skin cancer can only be a benefit to both doctors and patients," said Dr. Werschler.

About Dr. Kenneth Beer, MD, PA

Dr. Beer is board certified in both dermatology and dermatopathology, the microscopic study of the skin. He is one of the few cosmetic and surgical dermatologists to be credentialled in both specialties. Dr. Beer completed his residency in dermatology and fellowship in dermatopathology at the University of Chicago. He is a voluntary assistant professor at the University of Miami and a consulting associate in the department of medicine at Duke University.

Dr. Beer has authored numerous publications including several scientific articles and chapters in textbooks of cosmetic surgery and dermatology. Among the publications Dr. Beer has published are articles comparing various topical creams with Botox, different types of fillers used to treat nasolabial creases and a host of others that have advanced the field of dermatology. He is renowned as one of the country's top experts in Botox and has published extensively in cosmetic dermatology journals, including Cosmetic Dermatology, Dermatologic Surgery and is the author of the monthly Cosmetic Clinic for dermatologists that appears in Skin and Aging magazine. By combining his dermatology and dermatopathology expertise, Dr. Beer has become a leader in skin cancer surgery and reconstruction as well as cosmetic dermatology.

About Dr. Wm. Philip Werschler, MD, FAAD, FAACS

Dr. Werschler is the founding member of Spokane Dermatology Clinic and Werschler Aesthetics. Dr. Werschler has been an active teaching member of the University of Washington faculty for over 20 years, where he serves as a clinical professor in medicine/dermatology. A graduate of the George Washington University, School of Medicine, Washington, He is affiliated with several professional societies, including a full fellow of the American Academy of Dermatology, the American Academy of Cosmetic Surgery, American Society for Dermatological Surgery and the American Society for Mohs Surgery.

Dr. Werschler has contributed extensively to the dermatologic literature and is the founding aesthetic editor in chief of the Journal of Clinical and Aesthetic Dermatology, a leading PubMed-listed specialty journal. Dr. Werschler is also the editor in chief of Cosmetic Dermatology, the specialty's original journal for cosmetic and aesthetic dermatology. He is on the editorial boards of multiple scholarly journals including Skin and Aging Cutis, and the Journal of Drugs in Dermatology. Dr. Werschler lectures both nationally and internationally on advances in the field of dermatology, aesthetic medicine and surgery.

We seek Safe Harbor.